Feinstein Institutes awarded $3.37 million grant to boost first responder mental health
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Clinical trials found that 77% of patients went into remission after receiving obe-cel
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Desai is currently serving the company as Group Finance Controller
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
India presents one of the world’s largest untapped opportunities for neurovascular screening
Subscribe To Our Newsletter & Stay Updated